دورية أكاديمية
أعرض في EDS

Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?

التفاصيل البيبلوغرافية
العنوان: Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?
المؤلفون: Khan Z; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530 China.; University of Chinese Academy of Sciences, Beijing 100049, China.; Center for Biotechnology and Microbiology, University of Swat, Pakistan., Ahmad U; Center for Biotechnology and Microbiology, University of Swat, Pakistan., Ualiyeva D; University of Chinese Academy of Sciences, Beijing 100049, China.; Department of Herpetology, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.; Faculty of Biology and Biotechnology, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan., Amissah OB; University of Chinese Academy of Sciences, Beijing 100049, China., Khan A; Ministry of Education, Key Laboratory of Cell Activities and Stress Adaptations, School of life sciences, Lanzhou University, 730000 Gansu, China., Noor Z; CAS Key Laboratory of Tropical Marine Bio-Resources and Ecology, Guangdong, China.; Key Laboratory of Applied Marine Biology, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou, China., Zaman N; Center for Biotechnology and Microbiology, University of Swat, Pakistan.
المصدر: Clinical immunology communications [Clin Immunol Commun] 2022 Dec; Vol. 2, pp. 1-5. Date of Electronic Publication: 2021 Dec 23.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918697481206676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2772-6134 (Electronic) Linking ISSN: 27726134 NLM ISO Abbreviation: Clin Immunol Commun Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [New York] : Elsevier Inc., [2021]-
مستخلص: SARS-CoV-2 causes Coronavirus Disease 2019 (COVID-19), an infectious condition that can present none or one or more of these symptoms: fever, cough, headache, sore throat, loss of taste and smell, aches, fatigue and musculoskeletal pain. For the prevention of COVID-19, there are vaccines available including those developed by Pfizer, Moderna, Sinovac, Janssen, and AstraZeneca. Recent evidence has shown that some COVID-19-vaccinated individuals can occasionally develop as a potential side effect Guillain-Barre syndrome (GBS), a severe neurological autoimmune condition in which the immune response against the peripheral nerve system (PNS) can result in significant morbidity. GBS had been linked previously to several viral or bacterial infections, and the finding of GBS after vaccination with certain COVID-19, while rare, should alert medical practitioners for an early diagnosis and targeted treatment. Here we review five cases of GBS that developed in different countries after COVID-19 vaccination.
Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(© 2021 The Authors. Published by Elsevier Inc.)
References: Ann Neurol. 1992 Jun;31(6):677-9. (PMID: 1514781)
Sleep Med. 2022 Mar;91:231-236. (PMID: 34321155)
Vet Microbiol. 2020 May;244:108693. (PMID: 32402329)
NPJ Vaccines. 2021 Feb 22;6(1):28. (PMID: 33619260)
Pediatr Neurol. 2012 Aug;47(2):91-6. (PMID: 22759683)
Environ Res. 2021 Sep;200:111752. (PMID: 34302822)
PLoS One. 2007 Apr 04;2(4):e344. (PMID: 17406668)
J Environ Public Health. 2021 May 11;2021:5524098. (PMID: 34054974)
J Med Virol. 2020 Apr;92(4):418-423. (PMID: 31967327)
Tohoku J Exp Med. 2020;250(4):271-278. (PMID: 32321874)
J Peripher Nerv Syst. 2018 Sep;23(3):154-158. (PMID: 29603827)
Neurology. 2007 Nov 27;69(22):2105-7. (PMID: 18040016)
Lancet. 2016 Aug 13;388(10045):717-27. (PMID: 26948435)
Eur Arch Otorhinolaryngol. 2021 Apr;278(4):1233-1236. (PMID: 32875391)
JAAD Case Rep. 2021 Apr;10:92-95. (PMID: 33748377)
J Infect Chemother. 2012 Feb;18(1):119-23. (PMID: 21915637)
J Med Virol. 2021 Jul;93(7):4054-4057. (PMID: 33675239)
Cell Mol Immunol. 2020 May;17(5):554. (PMID: 32024976)
Ann Neurol. 2021 Aug;90(2):315-318. (PMID: 34114269)
Adv Drug Deliv Rev. 2021 Mar;170:83-112. (PMID: 33400957)
JAMA. 2004 Nov 24;292(20):2478-81. (PMID: 15562126)
Soc Sci Med. 2021 Jan;268:113426. (PMID: 33199035)
Drugs. 2021 Jan;81(1):183. (PMID: 33331990)
Cell. 2020 Oct 1;183(1):16-27.e1. (PMID: 32882182)
JAMA Netw Open. 2021 Jan 4;4(1):e2035057. (PMID: 33410879)
N Engl J Med. 2020 Nov 12;383(20):1920-1931. (PMID: 32663912)
Eur Respir J. 2020 Jun 4;55(6):. (PMID: 32269086)
Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759. (PMID: 32663409)
Aging (Albany NY). 2020 May 29;12(10):9959-9981. (PMID: 32470948)
Curr Res Toxicol. 2021;2:159-168. (PMID: 33688633)
Postgrad Med J. 2022 May 1;98(1159):389-394. (PMID: 37066438)
Pathogens. 2020 Mar 04;9(3):. (PMID: 32143502)
BMJ Case Rep. 2021 Jul 30;14(7):. (PMID: 34330729)
Int J Surg. 2020 Apr;76:71-76. (PMID: 32112977)
Curr Opin Infect Dis. 2003 Oct;16(5):375-81. (PMID: 14501988)
Crit Rev Microbiol. 2009;35(1):1-22. (PMID: 19514906)
Glob Transit. 2020;2:76-82. (PMID: 32835202)
Can J Neurol Sci. 1994 May;21(2):S23-7. (PMID: 8087730)
Neurosci Res. 2020 Sep;158:1-5. (PMID: 32628969)
Clin Immunol. 2020 Jun;215:108427. (PMID: 32325252)
Acta Neurol Scand. 2001 May;103(5):278-87. (PMID: 11328202)
Int J Biol Macromol. 2021 Oct 1;188:740-750. (PMID: 34403674)
Viruses. 2020 Nov 11;12(11):. (PMID: 33187074)
New Microbes New Infect. 2020 Nov;38:100770. (PMID: 33014380)
Biology (Basel). 2021 Aug 05;10(8):. (PMID: 34439984)
Lancet. 2005 Nov 5;366(9497):1653-66. (PMID: 16271648)
Front Public Health. 2020 Aug 13;8:473. (PMID: 32903584)
Neurol Clin. 2013 May;31(2):491-510. (PMID: 23642721)
فهرسة مساهمة: Keywords: AstraZeneca; Autoimmune; COVID-19; Guillain-Barre syndrome; Moderna; Pfizer; Vaccine
تواريخ الأحداث: Date Created: 20240415 Latest Revision: 20240418
رمز التحديث: 20240418
مُعرف محوري في PubMed: PMC8697478
DOI: 10.1016/j.clicom.2021.12.002
PMID: 38620684
قاعدة البيانات: MEDLINE
الوصف
تدمد:2772-6134
DOI:10.1016/j.clicom.2021.12.002